Family Medicine Doctors in Midway, UT Accepting Medicare
5 Family Medicine doctors found. Showing 1 - 5
 Dr. Terrell Lee Sellers, M.D Family Medicine - Addiction Medicine Medicare: Medicare Enrolled Practice Location: 100 N Johnson Mill Rd, Midway, UT 84049 Phone: 435-654-3700 Fax: 435-654-7111 |
Gerald L Hayward, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 909 Kohler Ln, Midway, UT 84049 Phone: 435-654-5702 |
Neil Drew Christensen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 380 E Main St # B-120, Midway, UT 84049 Phone: 435-214-7282 Fax: 928-433-4666 |
Jack L Cox, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1588 N Dutch Meadows Ln, Midway, UT 84049 Phone: 949-355-9043 |
 Dr. Judith S Moore, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 E Main St, Ste 101, Midway, UT 84049 Phone: 435-657-1777 Fax: 435-657-0098 |
News Archive
LabCorp to market On-Q-ity's circulating tumor cell platform
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
Baby food companies to be exposed as international monitors present evidence at UK Parliament
Members of the International Baby Food Action Network (IBFAN) will be presenting evidence gathered through monitoring of baby food companies in 69 countries at the House of Commons on 13 May from 10.30 to 11.30 am. The evidence shows how companies aggressively promote their products and undermine breastfeeding, thereby contributing to the unnecessary death and suffering of infants around the world.
Genocea Biosciences, NMRC sign CRADA to develop vaccine against malaria
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center. NMRC will collaborate with Genocea to identify antigens that will be used in the development of a vaccine candidate against Plasmodium falciparum for the prevention of malaria.
Experimental drug may prevent development of multiple sclerosis in mice
The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology.
› Verified 3 days ago